Stock listing

LSE:CRTX CRISM Therapeutics Corporation Share Price

Home listing (LSE) of CRISM Therapeutics Corporation

Follow CRISM Therapeutics Corporation into a list and get an email when it puts out news.

Share price · LSE:CRTX

8.75p GBX (pence) 0.00 (0.0%)

Close on Nov 5, 2026

Past year -27.1% · daily closes, Nov 5, 2025 – Nov 5, 2026, adjusted for splits
Day range
8.50p – 8.92p GBX (pence)Nov 5, 2026
Volume
23,146 sharesNov 5, 2026
Market cap
£6.97M GBPAt the close on Nov 5, 2026 · price × 79.66M shares outstanding
52-week range
8.00p – 18.50p GBX (pence)Lowest and highest trades, Nov 6, 2025 – Nov 5, 2026
Traded on an average day
£23,608 GBPMedian day 68,355 shares · last 3 months, Aug 5, 2026 – Nov 5, 2026
CRISM Therapeutics Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
LSE:CRTX · Home8.75p GBX (pence)0.00 (0.0%)23,1468.50p8.92p8.50p8.75pClose on Nov 5, 2026

Daily closes

Last 3 months, Aug 5, 2026 – Nov 5, 2026 · LSE:CRTX · GBX (pence), adjusted for splits

DayCloseChange%OpenHighLowVolume
8.75p0.000.0%8.50p8.92p8.50p23,146
8.75p0.000.0%8.54p9.00p8.50p9,484
8.75p0.000.0%8.97p8.97p8.50p139,853
8.75p0.000.0%9.00p9.00p8.50p151,088
8.75p0.000.0%9.00p9.00p8.54p10,947
8.75p0.000.0%8.50p8.75p8.50p2,254
8.75p0.000.0%8.80p9.00p8.50p55,883
8.75p0.000.0%9.00p9.00p8.50p221,016
8.75p0.000.0%8.69p9.00p8.50p63,125
8.75p0.000.0%9.00p9.00p8.50p6,133
8.75p0.000.0%8.75p8.75p8.55p4,594
8.75p0.000.0%8.75p9.00p8.50p1,763
8.75p-0.25-2.8%9.00p9.50p8.50p88,411
9.00p0.000.0%9.00p9.50p8.50p3,968
9.00p0.000.0%9.00p9.00p8.50p12,500
9.00p+0.25+2.9%9.00p9.19p8.50p5,878
8.75p0.000.0%8.75p9.00p8.75p84,289
8.75p-0.25-2.8%9.00p9.50p8.575p72,490
9.00p0.000.0%9.00p9.50p8.50p21,034
9.00p-0.25-2.7%9.25p9.50p8.65p159,596
9.25p0.000.0%9.25p9.25p9.00p24,463
9.25p0.000.0%9.25p9.50p9.00p81,658
9.25p0.000.0%9.25p9.50p9.00p17,748
9.25p0.000.0%9.25p9.50p9.00p71,557
9.25p-0.25-2.6%9.50p10.00p9.00p157,533
9.50p0.000.0%9.50p10.00p9.50p3,374
9.50p0.000.0%9.50p10.00p9.00p9,535
9.50p0.000.0%9.50p10.00p9.01p139,177
9.50p-0.25-2.6%9.75p10.00p9.15p56,488
9.75p0.000.0%9.75p10.00p9.50p29,665
9.75p0.000.0%9.75p9.85p9.75p48,419
9.75p0.000.0%9.75p10.00p9.50p36,472
9.75p0.000.0%9.75p9.90p9.50p23,765
9.75p0.000.0%9.75p10.00p9.50p8,390
9.75p0.000.0%9.75p9.95p9.60p63,617
9.75p-1.00-9.3%10.75p11.00p9.50p658,433
10.75p-0.50-4.4%11.25p12.00p10.50p180,987
11.25p0.000.0%11.25p11.25p10.55p14,177
11.25p0.000.0%11.25p12.00p10.50p216,084
11.25p0.000.0%11.25p11.25p11.19p13,359
11.25p0.000.0%11.25p12.00p10.50p7,953
11.25p0.000.0%11.25p11.25p10.50p3,297
11.25p0.000.0%11.25p11.25p10.50p12,486
11.25p0.000.0%11.25p12.00p10.86p150,646
11.25p0.000.0%11.25p12.00p10.50p14,107
11.25p0.000.0%11.25p12.00p10.50p326,617
11.25p0.000.0%11.25p11.30p10.76p302,346
11.25p-0.25-2.2%11.50p12.00p11.00p965,050
11.50p0.000.0%11.50p11.50p11.00p65,152
11.50p0.000.0%11.50p12.00p11.00p123,215
11.50p0.000.0%11.50p12.00p11.00p18,940
11.50p0.000.0%11.50p12.00p11.32p390,124
11.50p+0.25+2.2%11.50p12.00p11.31p112,778
11.25p0.000.0%11.25p11.50p11.22p1,089,164
11.25p0.000.0%11.25p11.50p11.20p684,407
11.25p+0.50+4.7%10.99p11.50p10.99p1,277,889
10.75p0.000.0%10.75p11.50p10.67p885,804
10.75p0.000.0%10.75p11.50p10.00p1,647,839
10.75p0.000.0%10.75p11.50p10.55p511,496
10.75p+0.75+7.5%10.25p11.50p10.00p1,077,982
10.00p0.000.0%10.00p10.00p9.50p13,854
10.00p0.000.0%10.00p10.50p9.50p1,232,583
10.00p+0.50+5.3%9.50p10.50p9.00p449,478
9.50p0.000.0%9.50p10.00p9.00p85,673
9.50p0.000.0%9.50p10.00p9.00p137,456
9.50p0.000.0%9.50p10.00p9.37p152,781
Ticker
LSE:CRTX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
LSE
Currency
GBX

What changed lately

Calls

Replays

  • CRISM Therapeutics (LSE:CRTX) — Investor Presentation

    Thu, Dec 11, 2025 · 7:00 AM ET

    Watch Transcript

  • CRISM Therapeutics (LSE:CRTX) — Interim Results

    Tue, Sep 16, 2025 · 7:00 AM ET

    Watch Transcript

  • CRISM Therapeutics (LSE:CRTX) — Interim Results

    Thu, Sep 19, 2024 · 7:00 AM ET

    Watch Transcript

Latest news

Holding(s) in Company

Nov 2, 2026

Closed 8.75p (0.0%) on Nov 2, 2026

Result of AGM

Oct 27, 2026

Closed 8.75p (0.0%) on Oct 27, 2026

AGM Statement

Oct 27, 2026

Closed 8.75p (0.0%) on Oct 27, 2026

Issue of Equity

Oct 15, 2026

Closed 9.00p (+2.9%) on Oct 15, 2026

Notice of AGM

Oct 2, 2026

Closed 9.25p (-2.6%) on Oct 2, 2026

Appointment of Non-executive Chair

Sep 17, 2026

Closed 9.75p (-9.3%) on Sep 17, 2026

Commencement of Patient Recruitment

Aug 20, 2026

Closed 11.25p (0.0%) on Aug 20, 2026

Result of Shareholder Analysis

Jul 27, 2026

Closed 9.50p (0.0%) on Jul 27, 2026

Grant of Options

Jun 30, 2026

Closed 9.75p (-2.5%) on Jun 30, 2026

Final results

Jun 26, 2026

Closed 10.00p (0.0%) on Jun 26, 2026

All CRISM Therapeutics Corporation news

Financings

  • Ordinary shares (retail offer)

    Jul 3, 2025 · US$73,703

    Closed: £54,021 raised · GBX 12 a share

    Use of proceeds: GMP manufacture of a ChemoSeed clinical trial batch, MHRA Clinical Trial Authorisation process and first patients dosed in Phase 2 trial in early 2026

    Announced Jun 30, 2025 · Closed Jul 3, 2025

  • Private placement of new ordinary shares

    Jul 3, 2025 · US$27,287

    Announced: £20,000

    Use of proceeds: GMP manufacture of a ChemoSeed clinical trial batch, MHRA Clinical Trial Authorisation process and first patients dosed in Phase 2 trial in early 2026

    Announced Jul 3, 2025

  • Private placement of new ordinary shares with attaching warrants

    Jun 30, 2025 · US$1.1M

    Announced: £800,000 · GBX 12 a share · 1 warrant at GBX 24 for 24 months · SP Angel Corporate Finance LLP

    Dealers: SP Angel Corporate Finance LLP (lead)

    Buyers: Andrew Webb (291,667 Placing Shares; 16.22% following Admission); Gerry Beaney (112,500 Placing Shares; 0.40% following Admission)

    Insiders: CEO Andrew Webb subscribed for 291,667 Placing Shares and Non-Executive Director Gerry Beaney for 112,500; related party transactions under AIM Rule 13

    Use of proceeds: GMP manufacture of a clinical batch of ChemoSeed and clinical trial set-up for a Phase 2 glioblastoma trial, with first patients dosed in early 2026

    Announced Jun 30, 2025

Read by 6ix AI from the company's releases

CRISM Therapeutics Corporation on 6ix

Sector
Health care
Industry
Biotechnology
News releases
24 in the last 12 months · 49 in all · newest Nov 2, 2026 · oldest 2024
Calls
4 calls with a replay · 4 with a transcript · latest Dec 11, 2025

Where CRISM Therapeutics Corporation is listed

ListingExchangeCountryCurrency
LSE:CRTX · Home listing · This pageLSEUnited KingdomGBX
AQUIS:AMC.GBAQUISUnited KingdomGBX

Log in to ask 6ix AI your own questions about CRISM Therapeutics Corporation.